Des directives anticipées aux discussions anticipées sur la fin de vie: From living wills to end-of-life discussions

Autor: Dhalluin, X., Lenoir, F., Vinant, P. ^*

Publikováno v: In Revue des Maladies Respiratoires Actualités October 2023 15(2) Supplement 1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of Fungus-Growing Termite Species on Litter Incorporation in a Preforest Savanna (Cote D’ Ivoire)

Autor: Rouland, C., author, Lenoir, F., author, Abbadie, L., author, Kouassi, P., author, Lepage, M., author

Publikováno v: Social Insects and the Environment: Proceedings of the 11th International Congress of IUSSI, 1990 (International Union for the Study of Social Insects). :213-214

Expérience du dépistage auditif néo-natal systématique dans le département de l’Eure: A propos de 10 835 nouveau-nés

Autor: De Barros Boishardy, A., Moreau Lenoir, F., Brami, Ph., Kapella, M., Obstoy, M.-Fr., Amstutz-Montadert, I., Lerosey, Y.

Publikováno v: In Annales d'Otolaryngologie et de chirurgie cervico-faciale 2005 122(5):223-230

High-Throughput Screen for Inhibitors of Klebsiella pneumoniae Virulence Using a Tetrahymena pyriformis Co-Culture Surrogate Host Model.

Autor: Woods AL; Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Parker D; Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Glick MM; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Peng Y; Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Lenoir F; Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Mulligan E; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Yu V; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Piizzi G; Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Lister T; Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Lilly MD; Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Dzink-Fox J; Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Jansen JM; Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, Emeryville California 94608-2916, United States., Ryder NS; Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Dean CR; Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Smith TM; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Publikováno v: ACS omega [ACS Omega] 2022 Feb 01; Vol. 7 (6), pp. 5401-5414. Date of Electronic Publication: 2022 Feb 01 (Print Publication: 2022).